Valneva has an established and efficient global marketing and distribution network
With commercial sites in the US, Canada, UK, the European Nordic countries and Austria, Valneva is well positioned to directly serve the key markets for its own products.
More than 70% of Valneva’s product sales are generated by the Company’s own marketing and distribution network.
Valneva has dedicated offices in Montreal (Canada), London (UK), and Vienna (Austria) which focus on developing sales for the Company’s travel vaccines IXIARO®
in addition to selling third-party products.
In the US, Valneva manages the distribution of IXIARO®
to the US military, the Company’s largest customer for this vaccine, as well as the private market.
In the European Nordic countries, Valneva’s sales and marketing team has well-established commercial operations and intends to further expand its presence by broadening its current portfolio with complementary customer products.
In addition, Valneva is working with a number of country specific partners to ensure broad geographic availability of the products.
Current partners include GSK, PaxVax, Seqirus, Adimmune, and Biological E.Valneva's commercial officesValneva UKValneva SwedenValneva Canada